Home › Acute Myeloid Leukemia › Indiana › Gary
Acute Myeloid Leukemia clinical trials in Gary, IN
4 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Gary (within about 30 miles). Open a study to see who can join and how to contact the study team.
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- UChicago Medicine Northwest Indiana, Crown Point · 12 mi away
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- UChicago Medicine Northwest Indiana, Crown Point · 12 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- UChicago Medicine Northwest Indiana, Crown Point · 12 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- UChicago Medicine Northwest Indiana, Crown Point · 12 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX86 studies
- New York City, NY51 studies
- Boston, MA45 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH34 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Tampa, FL29 studies
- Atlanta, GA29 studies
- Chicago, IL27 studies
- Portland, OR25 studies
Other studies in Gary
- Lung Cancer5 studies
- Non-Small Cell Lung Cancer4 studies
- Ovarian Cancer4 studies
- Heart Failure4 studies
- Endometrial Cancer4 studies
- Atrial Fibrillation3 studies
- Breast Cancer3 studies
- Overweight3 studies
- Obesity3 studies
- Esophageal Adenocarcinoma3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.